Literature DB >> 12882983

Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope.

Marie-Anne Petit1, Colette Jolivet-Reynaud, Estelle Peronnet, Yvonne Michal, Christian Trépo.   

Abstract

Monoclonal antibody D32.10 produced by immunizing mice with a hepatitis C virus (HCV)-enriched pellet obtained from plasmapheresis of a chronically HCV1b-infected patient binds HCV particles derived from serum of different HCV1a- and HCV1b-infected patients. Moreover, this monoclonal has been shown to recognize both HCV envelope proteins E1 and E2. In an attempt to provide novel insight into the membrane topology of HCV envelope glycoproteins E1 and E2, we localized the epitope recognized by D32.10 on the E1 and/or E2 sequence using Ph.D.-12 phage display peptide library technology. Mimotopes selected from the phage display dodecapeptide library by D32.10 shared partial similarities with 297RHWTTQGCNC306 of the HCV E1 glycoprotein and with both 613YRLWHYPCT621 and 480PDQRPYCWHYPPKPC494 of the HCV E2 glycoprotein. Immunoreactivity of D32.10 with overlapping peptides corresponding to these three HCV regions confirmed these localizations and suggested that the three regions identified are likely closely juxtaposed on the surface of serum-derived particles as predicted by the secondary model structure of HCV E2 derived from the tick-borne encephalitis virus E protein. This assertion was supported by the detection of specific antibodies directed against these three E1E2 regions in sera from HCV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882983     DOI: 10.1074/jbc.M304047200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Clustering of rare peptide segments in the HCV immunome.

Authors:  Angela Stufano; Giovanni Capone; Barbara Pesetti; Lorenzo Polimeno; Darja Kanduc
Journal:  Self Nonself       Date:  2010-02-03

2.  Triosephosphate isomerase of Taenia solium (TTPI): phage display and antibodies as tools for finding target regions to inhibit catalytic activity.

Authors:  Víctor Sanabria-Ayala; Iaraset Belmont; Landa Abraham
Journal:  Parasitol Res       Date:  2014-10-03       Impact factor: 2.289

3.  Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins.

Authors:  Mike Flint; Carine Logvinoff; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Structural elucidation of critical residues involved in binding of human monoclonal antibodies to hepatitis C virus E2 envelope glycoprotein.

Authors:  Roxana E Iacob; Zhenyong Keck; Oakley Olson; Steven K H Foung; Kenneth B Tomer
Journal:  Biochim Biophys Acta       Date:  2008-01-11

5.  Characterization of functional hepatitis C virus envelope glycoproteins.

Authors:  Anne Op De Beeck; Cécile Voisset; Birke Bartosch; Yann Ciczora; Laurence Cocquerel; Zhenyong Keck; Steven Foung; François-Loïc Cosset; Jean Dubuisson
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.

Authors:  Shahzada Amir; Karsten Hartvigsen; Ayelet Gonen; Gregor Leibundgut; Xuchu Que; Erika Jensen-Jarolim; Oswald Wagner; Sotirios Tsimikas; Joseph L Witztum; Christoph J Binder
Journal:  J Lipid Res       Date:  2012-04-16       Impact factor: 5.922

7.  Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies.

Authors:  Babs E Verstrepen; Erik Depla; Christine S Rollier; Gwenny Mares; Joost A R Drexhage; Sofie Priem; Ernst J Verschoor; Gerrit Koopman; Christelle Granier; Marlène Dreux; François L Cosset; Geert Maertens; Jonathan L Heeney
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

Review 8.  GB Virus C/Hepatitis G Virus Envelope Glycoprotein E2: Computational Molecular Features and Immunoinformatics Study.

Authors:  Mohammad Mahdi Ranjbar; Khodayar Ghorban; Seyed Moayed Alavian; Hossein Keyvani; Maryam Dadmanesh; Abbas Roayaei Ardakany; Mohammad Hassan Motedayen; Alireza Sazmand
Journal:  Hepat Mon       Date:  2013-12-30       Impact factor: 0.660

Review 9.  Neutralizing antibodies and pathogenesis of hepatitis C virus infection.

Authors:  Samira Fafi-Kremer; Catherine Fauvelle; Daniel J Felmlee; Mirjam B Zeisel; Quentin Lepiller; Isabel Fofana; Laura Heydmann; Françoise Stoll-Keller; Thomas F Baumert
Journal:  Viruses       Date:  2012-10-09       Impact factor: 5.048

Review 10.  Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies.

Authors:  Catherine Fauvelle; Che C Colpitts; Zhen-Yong Keck; Brian G Pierce; Steven K H Foung; Thomas F Baumert
Journal:  Expert Rev Vaccines       Date:  2016-06-13       Impact factor: 5.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.